In-111 DTPA (AnazaoHealth Corporation)


Welcome to the PulseAid listing for the In-111 DTPA drug offered from AnazaoHealth Corporation. This Lead Chelating Activity [MoA],Lead Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AnazaoHealth Corporation
NON-PROPRIETARY NAME: In-111 DTPA
SUBSTANCE NAME: INDIUM IN-111 PENTETATE DISODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Lead Chelating Activity [MoA],Lead Chelator [EPC]
ROUTE: INTRATHECAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-06-19
END MARKETING DATE: 0000-00-00


In-111 DTPA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIn-111 DTPA from AnazaoHealth Corporation
LABELER NAME: AnazaoHealth Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 3.75(mCi/1.5mL)
START MARKETING DATE: 2012-06-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51808-125_0e714ae6-396c-4488-868e-bfe5fd446f3f
PRODUCT NDC: 51808-125
APPLICATION NUMBER:

Other INDIUM IN-111 PENTETATE DISODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationIn-111 DTPA
Medi-Physics, Inc. dba GE HealthcareIndium DTPA In 111